05.06.2014 Views

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

Prevention Guide - Safe Handling of Hazardous Drugs - Irsst

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

5. RECEIVING AND TRANSPORT<br />

5.3.2 Delivery Containers RATING: ++<br />

Ensure that the hazardous drug delivery containers from manufacturers and distributors are<br />

properly identified.<br />

RECOMMENDATIONS<br />

5.3.2.1 The Drug Purchasing Managers should ensure that:<br />

‣ the manufacturers and distributors package hazardous drugs separately from other<br />

drugs. This recommendation is generally applied in Canada by the distributors <strong>of</strong> the<br />

antineoplastic drugs used in oncology. Until regulatory consensus has been reached in<br />

Canada regarding the necessary precautions for other hazardous drugs, we feel it is not<br />

very realistic to require distributors to provide separate packaging and labeling for<br />

other drugs not used in oncology.<br />

‣ the manufacturers and distributors package antineoplastic drugs in a plastic bag placed<br />

inside a properly sealed cardboard box marked with the symbol C (cytotoxic). If this<br />

cardboard box is placed in a rigid delivery container, the container must also be<br />

marked with the symbol C (cytotoxic). The delivery container may contain other, nonhazardous<br />

drugs.<br />

‣ the distributor cleans the delivery containers regularly.<br />

For the sake <strong>of</strong> efficiency, these measures may be carried out at a regional or provincial<br />

level.<br />

<br />

ASHP, p. 1175 ♦ NIOSH, p. 12<br />

5.3.3 <strong>Handling</strong> <strong>Hazardous</strong> Drug Delivery Containers RATING: +++<br />

Ensure that hazardous drug delivery containers are unpacked in the Pharmacy<br />

Department.<br />

RECOMMENDATIONS<br />

5.3.3.1 The receiving dock workers should check the integrity <strong>of</strong> the delivery containers upon<br />

receipt; in the event <strong>of</strong> breakage or a damaged parcel likely to cause a spill, apply the Spill<br />

Protocol (Appendix 4).<br />

5.3.3.2 Delivery containers should immediately be taken by to the Pharmacy Department by the<br />

receiving dock workers or the distributor.<br />

5.3.3.3 The receiving dock or storeroom workers should not open the delivery containers. Only<br />

the Pharmacy Department workers are authorized to proceed with the unpacking and<br />

subsequent steps.<br />

5.3.3.4 The delivery containers should be handled with care to avoid breakage <strong>of</strong> the hazardous<br />

drug containers and should not be left unattended in a corridor.<br />

<br />

APES, p. 5-35 ♦ ASHP, p. 1175 ♦ OPQ, Section 6.2<br />

5-2 ASSTSAS PREVENTION GUIDE – SAFE HANDLING OF HAZARDOUS DRUGS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!